Skip to main content
. 2018 Dec 3;18:196. doi: 10.1186/s12935-018-0695-8

Fig. 5.

Fig. 5

The feature of GRIA2Q607R editing level in glioma samples. a The editing level of Q607R in different WHO glioma grade. b The editing level of Q607R in different TCGA subtype. c GRIA2Q607R editing level in CGGA datasets according to IDH status. d Comparison of the OS between high and low GRIA2Q607R editing group in patients with gliomas. e The relationship of ADAR1, ADAR2 and ADAR3 expression with GRIA2Q607R editing level in glioma by Pearson analysis. OS, overall survival; *P < 0.05; ns, indicates no significant